Ping An Biomedical enters patent purchase agreement for tumor cell technologies

PASW•2026-11-04

Ping An Biomedical agreed to buy three tumor cell technology patents from Future Biotechnology Group for $2.30 million.

1. Patent purchase agreement

Ping An Biomedical entered into an agreement to buy three tumor cell technology patents from Future Biotechnology Group, with consideration of $2.30 million.

Ping An Biomedical enters patent purchase agreement for tumor cell technologies

1. Patent purchase agreement

Related News

First Industrial Realty Trust announces dividend of R$ 0.232244648 per unit

World stocks rally as investors expect more political certainty after Democrats' win

Nasdaq trade halt: volatility trading pause at 12:55 p.m.

Itron VP David Marshall Wright reports disposal of $132,509.921 in common shares

Tanker freight rates climb to nearly $1 million a day as Gulf shipping disruptions intensify